Daptomycin

NDC 25021-179 · Sagent Pharmaceuticals

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength350 mg/7mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryNDA

Packages

25021-179-66 — 1 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIAL

25021-179-67 — 10 VIAL in 1 CARTON (25021-179-67) / 7 mL in 1 VIAL

25021-179-15 — 1 VIAL in 1 CARTON (25021-179-15) / 7 mL in 1 VIAL

25021-179-16 — 10 VIAL in 1 CARTON (25021-179-16) / 7 mL in 1 VIAL

J0878 — Injection, daptomycin, 1 mg Medicare Part B payment limit (ASP + 6%): $0.03

FDA lists these products with the same active ingredient.

0338-0712 — Daptomycin in Sodium Chloride, 0338-0714 — Daptomycin in Sodium Chloride, 0338-0716 — Daptomycin in Sodium Chloride, 0338-0718 — Daptomycin in Sodium Chloride, 0409-0120 — DAPTOMYCIN, 0409-0122 — DAPTOMYCIN, 14335-120 — daptomycin, 16729-434 — Daptomycin, 16729-435 — Daptomycin, 25021-174 — daptomycin, 31722-215 — Daptomycin, 31722-216 — Daptomycin, 42023-295 — Daptomycin, 43598-413 — Daptomycin, 43598-476 — Daptomycin, 55150-344 — DAPTOMYCIN, 60505-6229 — Daptomycin, 60977-145 — daptomycin, 63323-371 — Daptomycin, 67184-0549 — Daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.